Format

Send to

Choose Destination
J Alzheimers Dis. 2013;34(2):457-68. doi: 10.3233/JAD-122059.

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Author information

1
Siemens Molecular Imaging, Inc., Culver City, CA 90230, USA.

Abstract

Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease. We have developed a novel PHF-tau targeting positron emission tomography imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies. Here in, we describe the first human brain images with [F-18]-T807.

PMID:
23234879
DOI:
10.3233/JAD-122059
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for IOS Press
Loading ...
Support Center